The Effect of Myopenia on the Inflammatory Response Early after Colorectal Surgery

References

• Broughman JR, Williams GR, Deal AM, Yu H, Nyrop KA, et al.: Prevalence of sarcopenia in older patients with colorectal cancer. J Geriatr Oncol 6, 442–445, 2015. doi:10.1016/j.jgo.2015.08.005.
   PubMed Web of Science ®Google Scholar
• Fearon K, Evans WJ, and Anker SD: Myopenia-a new universal term for muscle wasting. J Cachexia Sarcopenia Muscle 2, 1–3, 2011. doi:10.1007/s13539-011-0025-7.
   PubMed Web of Science ®Google Scholar
• Malietzis G, Aziz O, Bagnall NM, Johns N, Fearon KC, et al.: The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review. Eur J Surg Oncol 41, 186–196, 2015. doi:10.1016/j.ejso.2014.10.056.
   PubMed Web of Science ®Google Scholar
• Lieffers JR, Bathe OF, Fassbender K, Winget M, and Baracos VE: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107, 931–936, 2012. doi:10.1038/bjc.2012.350.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, et al.: Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22, 2663–2668, 2015. doi:10.1245/s10434-014-4281-6.
   PubMed Web of Science ®Google Scholar
• Margadant CC, Bruns ER, Sloothaak DA, van Duijvendijk P, van Raamt AF, et al.: Lower muscle density is associated with major postoperative complications in older patients after surgery for colorectal cancer. Eur J Surg Oncol 42, 1654–1659, 2016. doi:10.1016/j.ejso.2016.05.040.
   PubMed Web of Science ®Google Scholar
• Rolland Y, Onder G, Morley JE, Gillette-Guyonet S, Abellan van Kan G, et al.: Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med 27, 423–447, 2011. doi:10.1016/j.cger.2011.03.008.
   PubMed Web of Science ®Google Scholar
• Beyer I, Mets T, and Bautmans I: Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 15, 12–22, 2012. doi:10.1097/MCO.0b013e32834dd297.
   PubMed Web of Science ®Google Scholar
• Sinclair M, Gow PJ, Grossmann M, and Angus PW: Review article: Sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 43, 765–777, 2016. doi:10.1111/apt.13549.
   PubMed Web of Science ®Google Scholar
• Wakabayashi H, and Sakuma K: Comprehensive approach to sarcopenia treatment. Curr Clin Pharmacol 9, 171–180, 2014. doi:10.2174/1574884708666131111192845.
   PubMedGoogle Scholar
• Meng SJ, and Yu LJ: Oxidative stress, molecular inflammation and sarcopenia. Int J Mol Sci 11, 1509–1526, 2010. doi:10.3390/ijms11041509.
   PubMed Web of Science ®Google Scholar
• Malietzis G, Johns N, Al-Hassi HO, Knight SC, Kennedy RH, et al.: Low muscularity and myosteatosis is related to the host systemic inflammatory response in patients undergoing surgery for colorectal cancer. Ann Surg 263, 320–325, 2012.
   Web of Science ®Google Scholar
• Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, et al.: The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One 7, e41883, 2012. doi:10.1371/journal.pone.0041883.
   PubMed Web of Science ®Google Scholar
• Reisinger KW, Derikx JP, van Vugt JL, Von Meyenfeldt MF, Hulsewe KW, et al.: Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer. Clin Nutr 35, 924–927, 2016.
   PubMed Web of Science ®Google Scholar
• Rettig TC, Verwijmeren L, Dijkstra IM, Boerma D, van de Garde EM, et al.: Postoperative interleukin-6 level and early detection of complications after elective major abdominal surgery. Ann Surg 263, 1207–1212, 2016.
   PubMed Web of Science ®Google Scholar
• Peters EG, De Jonge WJ, Smeets BJ, and Luyer MD: The contribution of mast cells to postoperative ileus in experimental and clinical studies. Neurogastroenterol Motil 27, 743–749, 2015. doi:10.1111/nmo.12579.
   PubMed Web of Science ®Google Scholar
• McSorley ST, Horgan PG, and McMillan DC: The impact of preoperative corticosteroids on the systemic inflammatory response and postoperative complications following surgery for gastrointestinal cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 101, 139–150, 2016. doi:10.1016/j.critrevonc.2016.03.011.
   PubMed Web of Science ®Google Scholar
• Chuang D, Paddison JS, Booth RJ, and Hill AG: Differential production of cytokines following colorectal surgery. ANZ J Surg 76, 821–824, 2006. doi:10.1111/j.1445-2197.2006.03877.x.
   PubMed Web of Science ®Google Scholar
• Marik PE, and Flemmer M: The immune response to surgery and trauma: Implications for treatment. J Trauma Acute Care Surg 73, 801–808, 2012. doi:10.1097/TA.0b013e318265cf87.
   PubMed Web of Science ®Google Scholar
• Szczepanik AM, Scislo L, Scully T, Walewska E, Siedlar M, et al.: IL-6 serum levels predict postoperative morbidity in gastric cancer patients. Gastric Cancer 14, 266–273, 2011. doi:10.1007/s10120-011-0039-z.
   PubMed Web of Science ®Google Scholar
• van den Heijkant TC, Costes LM, van der Lee DG, Aerts B, Osinga-de Jong M, et al.: Randomized clinical trial of the effect of gum chewing on postoperative ileus and inflammation in colorectal surgery. Br J Surg 102, 202–211, 2015. doi:10.1002/bjs.9691.
   PubMed Web of Science ®Google Scholar
• Berghmans TM, Hulsewe KW, Buurman WA, and Luyer MD: Stimulation of the autonomic nervous system in colorectal surgery: A study protocol for a randomized controlled trial. Trials 13, 93, 2012. doi:10.1186/1745-6215-13-93.
   PubMed Web of Science ®Google Scholar
• Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, et al.: A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997–1006, 2008. doi:10.1139/H08-075.
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al.: Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31, 1539–1547, 2013. doi:10.1200/JCO.2012.45.2722.
   PubMed Web of Science ®Google Scholar
• Lantz M, Malik S, Slevin ML, and Olsson I: Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans. Cytokine 2, 402–406, 1990. doi:10.1016/1043-4666(90)90048-X.
   PubMedGoogle Scholar
• Dindo D, Demartines N, and Clavien PA: Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240, 205–213, 2004. doi:10.1097/01.sla.0000133083.54934.ae.
   PubMed Web of Science ®Google Scholar
• Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, et al.: Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100, 1236–1239, 2009. doi:10.1038/sj.bjc.6604997.
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Horie T, and Kubota K: Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246, 1047–1051, 2007. doi:10.1097/SLA.0b013e3181454171.
   PubMed Web of Science ®Google Scholar
• De Magistris L, Paquette B, Orry D, Facy O, Di Giacomo G, et al.: Preoperative inflammation increases the risk of infection after elective colorectal surgery: Results from a prospective cohort. Int J Colorectal Dis 31, 1611–1617, 2016. doi:10.1007/s00384-016-2620-8.
   PubMed Web of Science ®Google Scholar
• Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, et al.: The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: A systematic review and meta-analysis. Ann Surg Oncol 21, 3938–3946, 2014. doi:10.1245/s10434-014-3815-2.
   PubMed Web of Science ®Google Scholar
• Nozoe T, Matsumata T, and Sugimachi K: Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer. Am J Clin Oncol 23, 263–266, 2000. doi:10.1097/00000421-200006000-00011.
   PubMed Web of Science ®Google Scholar
• Canna K, McArdle PA, McMillan DC, McNicol AM, Smith GW, et al.: The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92, 651–654, 2005. doi:10.1038/sj.bjc.6602419.
   PubMed Web of Science ®Google Scholar
• Du Clos TW, and Mold C: C-reactive protein: An activator of innate immunity and a modulator of adaptive immunity. Immunol Res 30, 261–277, 2004. doi:10.1385/IR:30:3:261.
   PubMed Web of Science ®Google Scholar
• Remick DG: Interleukin-8. Crit Care Med 33, S466–S467, 2005. doi:10.1097/01.CCM.0000186783.34908.18.
   PubMed Web of Science ®Google Scholar
• Striz I, and Trebichavsky I: Calprotectin–A pleiotropic molecule in acute and chronic inflammation. Physiol Res 53, 245–253, 2004.
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, Horgan PG, and McMillan DC: The perioperative immune/inflammatory insult in cancer surgery: Time for intervention? Oncoimmunology 2, e27324, 2013. doi:10.4161/onci.27324.
   PubMed Web of Science ®Google Scholar
• Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, et al.: The systemic immune response to trauma: An overview of pathophysiology and treatment. The Lancet 384, 1455–1465, 2014. doi:10.1016/S0140-6736(14)60687-5.
   PubMed Web of Science ®Google Scholar
• Lopez MC, Efron PA, Ozrazgat-Baslanti T, Zhang J, Cuschieri J, et al.: Sex-based differences in the genomic response, innate immunity, organ dysfunction, and clinical outcomes after severe blunt traumatic injury and hemorrhagic shock. J Trauma Acute Care Surg 81, 478–485, 2016. doi:10.1097/TA.0000000000001113.
   PubMed Web of Science ®Google Scholar
• Leung KL, Lai PB, Ho RL, Meng WC, Yiu RY, et al.: Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: A prospective randomized trial. Ann Surg 231, 506–511, 2000. doi:10.1097/00000658-200004000-00008.
   PubMed Web of Science ®Google Scholar
• Catena F, Ansaloni L, Avanzolini A, Di Saverio S, D'Alessandro L, et al.: Systemic cytokine response after emergency and elective surgery for colorectal carcinoma. Int J Colorectal Dis 24, 803–808, 2009. doi:10.1007/s00384-009-0677-3.
   PubMed Web of Science ®Google Scholar
• Subramaniam K, Fallon K, Ruut T, Lane D, McKay R, et al.: Infliximab reverses inflammatory muscle wasting (sarcopenia) in Crohn's disease. Aliment Pharmacol Ther 41, 419–428, 2015. doi:10.1111/apt.13058.
   PubMed Web of Science ®Google Scholar
• Scheinfeld N: A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 15, 280–294, 2004. doi:10.1080/09546630410017275.
   PubMedGoogle Scholar